Article
Single nucleotide polymorphisms in the cannabinoid CB2 receptor: Molecular pharmacology and disease associations.
British journal of pharmacology - 1 Aug 2024
Foyzun Tahira, Whiting Maddie, Velasco Kate K, Jacobsen Jessie C, Connor Mark, Grimsey Natasha L
Abstract excerpt
Preclinical evidence implicating cannabinoid receptor 2 (CB2) in various diseases has led researchers to question whether CB2 genetics influence aetiology or progression. Associations between conditions and genetic loci are often studied via single nucleotide polymorphism (SNP) prevalence in case versus control populations. In the CNR2 coding exon, ~36 SNPs have high overall population prevalence (minor allele...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
